Apr 16, 2026 06:50AM Eton Pharmaceuticals names new CFO in planned succession

Mar 23, 2026 06:46AM Eton Pharmaceuticals (ETON) PT Raised to $52 at H.C. Wainwright

Mar 20, 2026 12:31PM Eton Pharmaceuticals (ETON) PT Raised to $52 at H.C. Wainwright

Mar 20, 2026 07:03AM Eton Pharmaceuticals (ETON) PT Raised to $31 at B.Riley

Mar 19, 2026 04:16PM Eton Pharmaceuticals Inc. (ETON) Tops Q4 EPS by 1c

Feb 2, 2026 06:51AM Eton Pharmaceuticals licenses rare disease product candidate

Nov 6, 2025 05:03PM Eton Pharmaceuticals Inc. (ETON) Misses Q3 EPS by 7c

Aug 7, 2025 04:21PM Eton Pharmaceuticals Inc. (ETON) Tops Q2 EPS by 2c, provides guidance

Jul 8, 2025 06:50AM FDA accepts Eton Pharmaceuticals' drug application for ET-600

Jun 27, 2025 06:51AM Eton Pharmaceuticals Inc. (ETON) Added to Russell 2000 and Russell 3000 Indexes

May 29, 2025 06:52AM Eton Pharmaceuticals (ETON) PT Raised to $35 at H.C. Wainwright

May 28, 2025 05:31PM Eton Pharmaceuticals Inc. (ETON) announces FDA approval for KHINDIVI oral

May 13, 2025 07:07PM Eton Pharmaceuticals Inc. (ETON) Tops Q1 EPS by 4c

Apr 1, 2025 07:01AM Eton Pharmaceuticals (ETON) Out-Licenses International Rights to Increlex

Mar 19, 2025 06:43AM H.C. Wainwright Reiterates Buy Rating on Eton Pharmaceuticals (ETON)

Mar 18, 2025 07:08AM Eton Pharmaceuticals Inc. (ETON) Misses Q4 EPS by 2c

Mar 14, 2025 06:52AM Eton Pharmaceuticals Inc. (ETON) Announces Positive Pivotal Clinical Study Results for ET-600

Mar 3, 2025 06:50AM Eton Pharmaceuticals Inc. (ETON) Announces Commercial Launch of Galzin Capsules

Feb 6, 2025 06:50AM Eton Pharmaceuticals (ETON) Announces Extension of PDUFA Goal Date for ET-400

Jan 24, 2025 06:39AM Eton Pharmaceuticals (ETON) PT Lowered to $33 at H.C. Wainwright

Jan 10, 2025 05:10AM B.Riley Starts Eton Pharmaceuticals (ETON ) at Buy

Jan 6, 2025 07:06AM Eton Pharmaceuticals (ETON) PT Raised to $17 at H.C. Wainwright

Jan 3, 2025 06:50AM Eton Pharmaceuticals Inc. (ETON) Acquires Galzin

Dec 20, 2024 06:51AM Eton Pharmaceuticals Inc. (ETON) Closes Acquisition of Increlex

Dec 17, 2024 06:51AM Eton Pharmaceuticals Inc. (ETON) Announces Final Readout of PKU GOLIKE Trial

Dec 3, 2024 06:51AM Eton Pharmaceuticals (ETON) Appoints Ipek Erdogan-Trinkaus as Chief Commercial Officer

Nov 26, 2024 06:59AM Eton Pharmaceuticals (ETON) PT Raised to $15 at H.C. Wainwright

Nov 25, 2024 06:51AM Eton Pharmaceuticals Inc. (ETON) Acquires US Rights to Amglidia

Nov 12, 2024 04:24PM Eton Pharmaceuticals Inc. (ETON) Tops Q3 EPS by 3c

Oct 28, 2024 09:31AM Eton Pharmaceuticals (ETON) PT Raised to $15 at Craig-Hallum

Oct 17, 2024 04:18PM SWK Holdings (SWKH) Provides Portfolio Update

Oct 17, 2024 04:15PM SWK Holdings Provides Portfolio Update

Oct 4, 2024 06:35AM Eton Pharmaceuticals (ETON) PT Raised to $11 at H.C. Wainwright

Oct 3, 2024 06:30AM Eton Pharmaceuticals (ETON) to Acquire Increlex from Ipsen

Aug 8, 2024 04:52PM Eton Pharmaceuticals Inc. (ETON) Misses Q2 EPS by 5c

Jul 17, 2024 04:15PM SWK Holdings Highlights Recent Achievements and Provides Portfolio Update

Jul 15, 2024 04:05PM Eton Pharmaceuticals Inc. (ETON) Announces FDA Acceptance of New Drug Application for ET-400